|
시장보고서
상품코드
2050741
멀티오믹스 시장 : 제품·서비스별, 유형별, 플랫폼별, 용도별, 최종사용자별, 지역별Global Multiomics Market, By Product & Service, By Type, By Platform, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 멀티오믹스 시장은 2026년에 28억 6,000만 달러로 추계되고 있으며, 2033년까지 78억 8,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 15.6%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 28억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 15.60% | 2033년 시장 규모 예측 : | 78억 8,000만 달러 |
멀티오믹스는 유전체학, 후성유전체학, 전사체학, 단백질체학, 대사체학 등 다양한 오믹스 기술을 결합하여 생물학적 시스템에 대한 포괄적인 지식을 얻을 수 있는 통합적 오믹스 접근법을 말합니다. 멀티오믹스는 여러 계층의 생물학적 데이터를 통합함으로써 단일 오믹스 접근법에 비해 분자 메커니즘, 경로, 네트워크에 대한 더 깊은 이해를 촉진합니다. 이를 통해 연구자들은 생물학적 과정과 표현형에 대한 보다 완전한 전체상을 파악할 수 있습니다. 건강 및 질병 연구에서의 통합오믹스 전략의 잠재력이 인식되면서 멀티오믹스 시장은 빠르게 성장하고 있습니다. 실험 기술, 생물정보학 툴 및 계산 능력의 발전으로 인해 생물 의학 연구에서의 멀티오믹스 적용이 더욱 가속화되고 있습니다.
시장 역학:
맞춤형 의료, 신약 개발 및 의약품 개발에서 멀티오믹스 도입 확대는 향후 수년간 멀티오믹스 시장의 성장을 촉진할 것으로 예상되는 주요 요인 중 일부입니다. 맞춤의료 분야에서는 환자의 분자 프로파일에 기반한 효과적이고 개별화된 치료법을 개발하기 위해 멀티오믹스 접근법이 점점 더 많이 활용되고 있습니다. 제약 기업도 새로운 약물 표적과 바이오마커를 발굴하고 정밀의료 개발을 위해 멀티오믹스를 활용하고 있습니다. 그러나 대규모의 복잡한 멀티오믹스 데이터세트가 야기하는 데이터 통합 및 관리의 어려움과 포괄적인 분석 툴의 부족은 시장 성장을 저해하는 요인으로 작용할 것으로 예상됩니다. 사용자 친화적인 데이터 분석 솔루션 개발, 데이터 처리 워크플로우 표준화, 오믹스 데이터 리포지토리 구축은 예측 기간 중 멀티오믹스 시장 기업에게 유망한 기회를 창출할 수 있습니다.
본 조사의 주요 특징:
- 이 조사에서는 각 부문의 잠재적인 매출 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 글로벌 멀티오믹스 시장의 주요 기업 개요을 작성하기 위해 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략 등 다양한 매개 변수를 기반으로 합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계의 멀티오믹스 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 멀티오믹스 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 멀티오믹스 시장 : 제품·서비스별, 2021-2033년
제5장 세계의 멀티오믹스 시장 : 유형별, 2021-2033년
제6장 세계의 멀티오믹스 시장 : 플랫폼별, 2021-2033년
제7장 세계의 멀티오믹스 시장 : 용도별, 2021-2033년
제8장 세계의 멀티오믹스 시장 : 최종사용자별, 2021-2033년
제9장 세계의 멀티오믹스 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.06.10Global Multiomics Market is estimated to be valued at USD 2.86 Bn in 2026 and is expected to reach USD 7.88 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.60% | 2033 Value Projection: | USD 7.88 Bn |
Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biological data, multiomics facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as researchers realize the potential of integrated omics strategies to study health and disease. Advancements in experimental techniques, bioinformatics tools, and computing power are further accelerating the application of multiomics in biomedical research.
Market Dynamics:
The growing adoption of multiomics in personalized medicine, drug discovery, and development are some of the key factors expected to drive the growth of the multiomics market in the coming years. Multiomics approaches are increasingly being used in personalized medicine to develop effective, individualized treatments based on a patient's molecular profile. Pharmaceutical companies are also leveraging multiomics to identify novel drug targets and biomarkers and develop precision therapeutics. However, data integration and management challenges posed by large and complex multiomics datasets as well as lack of comprehensive analytical tools are some of the factors expected to restrain the market growth. Development of user-friendly data analysis solutions, standardization of data processing workflows, and establishment of omics data repositories could create lucrative opportunities for multiomics market players over the forecast period.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global multiomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include BD, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global multiomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiomics market.
Detailed Segmentation:
- Global Multiomics Market, By Product & Service (Revenue, USD Bn, 2021 - 2033)
- Products
- Instruments
- Consumables
- Software
- Services
- Global Multiomics Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Single-cell Multiomics
- Bulk Multiomics
- Global Multiomics Market, By Platform (Revenue, USD Bn, 2021 - 2033)
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Integrated Omics Platforms
- Global Multiomics Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- AgriGenomics
- Others (Environmental Monitoring, etc.)
- Global Multiomics Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Clinical Research Organizations (CROs)
- Others (Hospitals and Diagnostic Centers, etc.)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Multiomics Market, Key Players
- BD
- Thermo Fisher Scientific Inc.
- Illumina, Inc
- Danaher, PerkinElmer Inc.
- Shimadzu Corporation
- Bruker
- QIAGEN
- Agilent Technologies, Inc.
- BGI
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Multiomics Market, By Product & Service
- Global Multiomics Market, By Type
- Global Multiomics Market, By Platform
- Global Multiomics Market, By Application
- Global Multiomics Market, By End User
- Global Multiomics Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing usage of multiomics in personalized medicine
- Growing investment in and funding of multiomics research
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service Offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Multiomics Market, By Product & Service, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Instruments
- Consumables
- Software
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Multiomics Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Single-cell Multiomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Bulk Multiomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Multiomics Market, By Platform, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Metabolomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Integrated Omics Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Multiomics Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Personalized Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- AgriGenomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others (Environmental Monitoring, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Multiomics Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Clinical Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others (Hospitals and Diagnostic Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
9. Global Multiomics Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- BD
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Illumina, Inc
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Danaher, PerkinElmer Inc.
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shimadzu Corporation
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bruker
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BGI
- Company Highlights
- Product & Service Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
